Tyra Biosciences (TYRA) Net Equity Issued and Repurchased (2021 - 2026)

Tyra Biosciences' (TYRA) quarterly Net Equity Issued and Repurchased came in at $147.9 million in Q1 2026, up 278.93% on a QoQ basis from -$82.6 million in Q3 2021.

Tyra Biosciences (TYRA) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends

Tyra Biosciences (TYRA) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $147.9 million in Q1 2026.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $147.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $147.9 million (changed N/A YoY) and the FY2021 annual result came in at $23.5 million, up 0.79% from the prior year.
  • Net Equity Issued and Repurchased improved to $147.9 million in Q1 2026, from -$82.6 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $147.9 million in Q1 2026 to a low of $147.9 million in Q1 2026.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Tyra Biosciences 1.51 Bn 1.51 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 147.85 Mn
Mar 31, 2026 147.85 Mn
Sep 30, 2021 -82.63 Mn
Sep 30, 2021 -82.63 Mn
Jun 30, 2021 28,000.00
Jun 30, 2021 28,000.00
Mar 31, 2021 106.10 Mn
Mar 31, 2021 106.10 Mn